Q-omics provides the consensus-scored TNFRSF6B profile across patient tissues and cancer cell-line models. Additionally, TNFRSF6B protein abundance shows 10,286 significant protein co-abundance associations, with the highest sampling consensus in LSCC.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for TNFRSF6B — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with TNFRSF6B in patient tissues and cancer cell lines. In patient samples, TNFRSF6B shows the broadest associations at the RNA and protein expression levels, with LSCC recurring as the lineage with the largest associated feature set. In cancer cell lines, TNFRSF6B RNA and mutation anchors are most strongly linked to RNA-expression features, especially in OVARY, while CRISPR and shRNA rows add functional-dependency signals in BLOOD_Lymphoma and BLOOD_Leukemia.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼Protein (mass-spec)
Protein (mass-spec)	10,286	LSCC (4150)	view →
RNA	5,229	LSCC (2432)	view →
▼RNA
RNA	2,232	SCLC (2232)	view →
Function (RNA)	422	SCLC (422)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼CRISPR
CRISPR	1,894	OVARY (165)	view →
RNA	1,323	BLOOD_Lymphoma (198)	view →
▼RNA
RNA	6,534	BLOOD_Leukemia (1598)	view →
Function (RNA)	2,639	SOFT_TISSUE (369)	view →
▼shRNA
shRNA	1,668	BLOOD_Leukemia (143)	view →
RNA	1,570	SOFT_TISSUE (227)	view →
▼Mutation
Mutation	864	BLOOD_Leukemia (768)	view →
RNA	19	BLOOD_Leukemia (13)	view →